echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > East China Medicine Dopenketone Tablets Through Generic Drug Consistency Evaluation

    East China Medicine Dopenketone Tablets Through Generic Drug Consistency Evaluation

    • Last Update: 2020-06-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Table 1: Basic severity of approved productsSource: Company Announcementit is understood that dopensone tablets are a strong dopamine receptor antagonist developed by Janssen ( Jansen) Belgium in 1978 and are widely used for the treatment of nausea and vomitingIn 1980, Janssen produced dopenketone tablets licensed by France and was listed in FranceIn 1989, Belgian Janssen's joint venture in China, Xi'an Yangsen Pharmaceutical Co., Ltdproduced dopeightone tablets in China was approved for listing, the specification of 10 mg, the commodity name ding's, is the original research real estate productsFigure 1: Sales of dopenemin tablets (units: 10,000 yuan)Source: Mine Net China Public Medical Institution Seterminal Competition PatternMinet Net Data show that in 2019 in China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminal gastrointestinal antisenteric drugs and anticholinergic drugs TOP20, polypenone tablets ranked third in sales of more than 5.6 billion yuanXi'an Bohua's sales were 10.86 million yuan, and its market share rose to 1.93 percentEast China Pharmaceuticals said that up to now, the product in the generic consistency evaluation of research and development investment of about 11 million yuanFigure 2: Products currently evaluated by East China PharmaceuticalsSource: Minnet Consistency Evaluation DatabaseFigure 3: China East China Medicine is currently reviewing the consistency evaluation supplemental applicationSource: Minnet MED China Drug Review Database 2.0Mnet Net M ED China Drug Review Database 2.0 data show that up to now, There are 3 products in East China, the consistency evaluation supplement application in the review involves 6 products, of which pyrethyl metformin tablets, injectable sodium protoprazole is expected to win the first reviewSource: Company Announcement, Minnet DatabaseNote: Review Data Statistics As of June 8, 2020original title: "Attention" East China's third review product was born! 500 million varieties of "DingTing" has been rated by 3
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.